Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Clinical trial NCT01592500 · COMPLETED

Trial details

NCT number: NCT01592500
Sponsor: OPKO Health, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pediatric Growth Hormone Deficiency

Start date: 2012-02-01
Primary completion: 2015-07-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.